Galderma Laboratories Inc. v. Amneal Pharmaceuticals LLC
1:11-cv-01106
Overview
Parties
Defendant
Counter Claimant
Amneal Pharmaceuticals Co (I) Pvt Ltd Operating Company
Represented By
3 Attorneys ListedCounter Defendant
Galderma Laboratories LP NPE (Individual / Inventor)
Represented By
3 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 12 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → |
Amneal Pharamceuticals, LLC et al. v. Supernus Pharmaceuticals, Inc. et al.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7749532
Once daily formulations of tetracyclines
|
Filed: 2004-04-07
Issued: 2010-07-06
|
Active (1.1 yrs remaining)
+1351d PTA
Expires: 2027-12-19
|
|
|
US7232572
Methods of treating rosacea
|
Filed: 2005-02-18
Issued: 2007-06-19
|
Expired (Term Ended)
Expires: 2025-02-18
|
|
|
US7211267
Methods of treating acne
|
Filed: 2002-04-05
Issued: 2007-05-01
|
Expired (Term Ended)
Expires: 2022-04-05
|
|
|
US8206740
Once daily formulations of tetracyclines
|
Filed: 2008-06-06
Issued: 2012-06-26
|
Expired (Term Ended)
Expires: 2025-12-24
|
Patent Enforceability & Injunction Risk Assessment
Active Threat โ Patent is within enforceable statutory term; injunctive relief viable.
High PTA (+1351 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. ยง 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
38
Dispositive
1
Granted
4
Denied
1
Pending / Review
32
Motions by Category
Key Dispositive Motions & Rulings